[
1. Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289-1367. doi: 10.1093/eurheartj/ehaa575. Erratum in: Eur Heart J. 2021;42:1908. Erratum in: Eur Heart J. 2021;42:1925.32860058
]Open DOISearch in Google Scholar
[
2. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction. J Am Coll Cardiol. 2018;72:2231-2264. doi: 10.1016/j.jacc.2018.08.1038.30153967
]Open DOISearch in Google Scholar
[
3. Jaffe AS, Ordonez-Llanos J. High-sensitivity cardiac troponin: from theory to clinical practice. Rev Esp Cardiol (Engl Ed). 2013;66:687-691. doi: 10.1016/j.rec.2013.04.020.24773672
]Open DOISearch in Google Scholar
[
4. Arslan M, Dedic A, Boersma E, Dubois EA. Serial high-sensitivity cardiac troponin T measurements to rule out acute myocardial infarction and a single high baseline measurement for swift rule-in: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 2020;9:14-22. doi: 10.1177/2048872618819421.700855130618277
]Open DOISearch in Google Scholar
[
5. Lazar DR, Lazar FL, Homorodean C, et al. High-Sensitivity Troponin: A Review on Characteristics, Assessment, and Clinical Implications. Dis Markers. 2022;2022:9713326. doi: 10.1155/2022/9713326.896560235371340
]Open DOISearch in Google Scholar
[
6. Hinton J, Gabara L, Curzen N. Is the true clinical value of high-sensitivity troponins as a biomarker of risk? The concept that detection of high-sensitivity troponin ‘never means nothing’. Expert Rev Cardiovasc Ther. 2020;18:843-857. doi: 10.1080/14779072.2020.1828063.32966128
]Open DOISearch in Google Scholar
[
7. Giannitsis E, Gopi V. Biomarkers for infarct diagnosis and rapid rule-out/rule-in of acute myocardial infarction. Herz. 2020;45:509-519. English. doi: 10.1007/s00059-020-04943-x.32468140
]Open DOISearch in Google Scholar
[
8. Sandoval Y, Apple FS, Mahler SA, et al. High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain. Circulation. 2022;146:569-581. doi: 10.1161/CIRCULATIONAHA.122.059678.35775423
]Open DOISearch in Google Scholar
[
9. Mair J, Jaffe A, Lindahl B, et al. The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction – from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC). Biomarkers. 2022;27:407-417. doi: 10.1080/1354750X.2022.2055792.934493435603440
]Open DOISearch in Google Scholar
[
10. Kankra M, Mehta A, Sawhney JPS, et al. Improving the ACS Triage-Using High Sensitivity TroponinI and Copeptin for Early ‘Rule-Out’ of AMI. Indian J Clin Biochem. 2022;37:449-457. doi: 10.1007/s12291-021-01015-7.957383936262786
]Open DOISearch in Google Scholar
[
11. Giannitsis E, Garfias-Veitl T, Slagman A, et al. Biomarkers-in-Cardiology 8 RE-VISITED-Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal hs-cTnT with a Normal Copeptin in Low-to-Intermediate Risk Patients with Suspected Acute Coronary Syndrome – A Secondary Analysis of the Randomized Biomarkers-in-Cardiology 8 Trial. Cells. 2022;11:211. doi: 10.3390/cells11020211.877359235053326
]Open DOISearch in Google Scholar
[
12. Elseidy SA, Awad AK, Mandal D, Vorla M, Elkheshen A, Mohamad T. Copeptin plus troponin in the rapid rule out of acute myocardial infarction and prognostic value on post-myocardial infarction outcomes: a systematic review and diagnostic accuracy study. Heart Vessels. 2023;38:1-7. doi: 10.1007/s00380-022-02123-x.35794488
]Open DOISearch in Google Scholar
[
13. Ozden O, Yesildas C, Demir M, et al. A Novel Indicator of Myocardial Injury after Acute Myocardial Infarction: ‘DPP-3’. Clin Appl Thromb Hemost. 2022;28:10760296221145174. doi: 10.1177/10760296221145174.975634936514254
]Open DOISearch in Google Scholar
[
14. Udaya R, Sivakanesan R. Synopsis of Biomarkers of Atheromatous Plaque Formation, Rupture and Thrombosis in the Diagnosis of Acute Coronary Syndromes. Curr Cardiol Rev. 2022;18:53-62. doi: 10.2174/1573403X18666220411113450.35410616
]Open DOISearch in Google Scholar
[
15. Peacock WF, Maisel AS, Mueller C, et al. Finding acute coronary syndrome with serial troponin testing for rapid assessment of cardiac ischemic symptoms (FAST-TRAC): a study protocol. Clin Exp Emerg Med. 2022;9:140-145. doi: 10.15441/ceem.21.154.928888435843615
]Open DOISearch in Google Scholar
[
16. Crapnell RD, Dempsey NC, Sigley E, Tridente A, Banks CE. Electroanalytical point-of-care detection of gold standard and emerging cardiac biomarkers for stratification and monitoring in intensive care medicine – a review. Mikrochim Acta. 2022;189:142. doi: 10.1007/s00604-022-05186-9.891782935279780
]Open DOISearch in Google Scholar
[
17. Kleemeier S, Abildgaard A, Ladefoged SA, Thorsted Sørensen J, Stengaard C, Adelborg K. High-sensitivity troponin T and I in patients suspected of acute myocardial infarction. Scand J Clin Lab Invest. 2022;82:96-103. doi: 10.1080/00365513.2022.2033310.35253566
]Open DOISearch in Google Scholar
[
18. Younis A, Farooq S, Bisognano JD, et al. Outcomes Associated with Introduction of the 5th Generation High-Sensitivity Cardiac Troponin in Patients Presenting with Cardiovascular Disorders. J Emerg Med. 2022;62:657-667. doi: 10.1016/j.jemermed.2022.01.011.35382958
]Open DOISearch in Google Scholar
[
19. Bruinen AL, Frenk LDS, de Theije F, et al. Point-of-care high-sensitivity troponin-I analysis in capillary blood for acute coronary syndrome diagnostics. Clin Chem Lab Med. 2022;60:1669-1674. doi: 10.1515/cclm-2022-0268.35858956
]Open DOISearch in Google Scholar
[
20. Tveit SH, Myhre PL, Hanssen TA, et al. Cardiac troponin I and T for ruling out coronary artery disease in suspected chronic coronary syndrome. Sci Rep. 2022;12:945. doi: 10.1038/s41598-022-04850-7.876656435042885
]Open DOISearch in Google Scholar
[
21. Ravanavena A, Ravindra C, Igweonu-Nwakile EO, et al. Absolute Versus Relative Changes in Cardiac Troponins in the Diagnosis of Myocardial Infarction: A Systematic Review and Meta-Analysis. Cureus. 2022;14:e27414. doi: 10.7759/cureus.27414.933878335915617
]Open DOISearch in Google Scholar
[
22. Juknevičienė R, Juknevičius V, Jasiūnas E, et al. Chest pain in the emergency department: From score to core – A prospective clinical study. Medicine (Baltimore). 2022;101:e29579. doi: 10.1097/MD.0000000000029579.930235535866759
]Open DOISearch in Google Scholar
[
23. Lee KK, Bularga A, O’Brien R, et al. Troponin-Guided Coronary Computed Tomographic Angiography After Exclusion of Myocardial Infarction. J Am Coll Cardiol. 2021;78:1407-1417. doi: 10.1016/j.jacc.2021.07.055.848279334593122
]Open DOISearch in Google Scholar
[
24. Butt JH, Kofoed KF, Kelbæk H, et al. Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome: Insights From the VERDICT Trial. J Am Heart Assoc. 2021;10:e022333. doi: 10.1161/JAHA.121.022333.864912434585591
]Open DOISearch in Google Scholar
[
25. Gray AJ, Roobottom C, Smith JE, et al. Early computed tomography coronary angiography in adults presenting with suspected acute coronary syndrome: the RAPID-CTCA RCT. Health Technol Assess. 2022;26:1-114. doi: 10.3310/IRWI5180.36062819
]Open DOISearch in Google Scholar
[
26. Mehta P, McDonald S, Hirani R, Good D, Diercks D. Major adverse cardiac events after emergency department evaluation of chest pain patients with advanced testing: Systematic review and meta-analysis. Acad Emerg Med. 2022;29:748-764. doi: 10.1111/acem.14407.34741781
]Open DOISearch in Google Scholar
[
27. Williams MGL, Liang K, De Garate E, et al. Peak Troponin and CMR to Guide Management in Suspected ACS and Nonobstructive Coronary Arteries. JACC Cardiovasc Imaging. 2022;15:1578-1587. doi: 10.1016/j.jcmg.2022.03.017.36075617
]Open DOISearch in Google Scholar
[
28. Emakhu J, Monplaisir L, Aguwa C, et al. Acute coronary syndrome prediction in emergency care: A machine learning approach. Comput Methods Programs Biomed. 2022;225:107080. doi: 10.1016/j.cmpb.2022.107080.36037605
]Open DOISearch in Google Scholar
[
29. Ke J, Chen Y, Wang X, et al. Machine learning-based inhospital mortality prediction models for patients with acute coronary syndrome. Am J Emerg Med. 2022;53:127-134. doi: 10.1016/j.ajem.2021.12.070.35033770
]Open DOISearch in Google Scholar
[
30. Doudesis D, Lee KK, Yang J, et al. Validation of the myocardial-ischaemic-injury-index machine learning algorithm to guide the diagnosis of myocardial infarction in a heterogenous population: a prespecified exploratory analysis. Lancet Digit Health. 2022;4:e300-e308. doi: 10.1016/S2589-7500(22)00025-5.905233135461689
]Open DOISearch in Google Scholar
[
31. Mohan N, Shivakumar KM, Kl CK. Correlation of Troponin I with Left Ventricular Ejection Fraction in Acute Coronary Syndrome. J Assoc Physicians India. 2022;70:11-12. PMID: 35443386.
]Search in Google Scholar
[
32. Sadiq S, Ijaz A, Dawood MM, Sadiq T. B-type natriuretic peptide as diagnostic and prognostic marker in various forms of acute coronary syndrome. Pak J Med Sci. 2022;38:970-975. doi: 10.12669/pjms.38.4.4910.912192635634594
]Open DOISearch in Google Scholar
[
33. Kavsak PA, Mondoux SE, Hewitt MK, Ainsworth C, Hill S, Worster A. Can the Addition of NT-proBNP and Glucose Measurements Improve the Prognostication of High-Sensitivity Cardiac Troponin Measurements for Patients with Suspected Acute Coronary Syndrome? J Cardiovasc Dev Dis. 2021;8:106. doi: 10.3390/jcdd8090106.847114934564124
]Open DOISearch in Google Scholar
[
34. Ledwoch J, Schneider A, Leidgschwendner K, et al. Diagnostic Accuracy of High-Sensitive Troponin for the Identification of Myocardial Infarction in Patients Presenting with Acute Heart Failure. J Emerg Med. 2022;62:359-367. doi: 10.1016/j.jemermed.2021.11.013.35065860
]Open DOISearch in Google Scholar
[
35. Fermann GJ, Schrock JW, Levy PD, et al. Troponin is unrelated to outcomes in heart failure patients discharged from the emergency department. J Am Coll Emerg Physicians Open. 2022;3:e12695. doi: 10.1002/emp2.12695.899461635434709
]Open DOISearch in Google Scholar
[
36. Ratmann PD, Boeddinghaus J, Nestelberger T, et al. Extending the no objective testing rules to patients triaged by the European Society of Cardiology 0/1-hour algorithms. Eur Heart J Acute Cardiovasc Care. 2022;11:834-840. doi: 10.1093/ehjacc/zuac120.36179255
]Open DOISearch in Google Scholar
[
37. Wang JL, Guo CY, Li HW, Zhao XQ, Zhao SM. Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction. Am J Med Sci. 2022;363:333-341. doi: 10.1016/j.amjms.2021.10.017.34986361
]Open DOISearch in Google Scholar
[
38. Galvani M, Ottani F, Oltrona L, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation. 2004;110:128-34. doi: 10.1161/01.CIR.0000134480.06723.D8.15197143
]Open DOISearch in Google Scholar
[
39. Lu PJ, Gong XW, Liu Y, et al. Optimization of GRACE Risk Stratification by N-Terminal Pro-B-type Natriuretic Peptide Combined With D-Dimer in Patients With Non-ST-Elevation Myocardial Infarction. Am J Cardiol. 2021;140:13-19. doi: 10.1016/j.amjcard.2020.10.050.33159905
]Open DOISearch in Google Scholar
[
40. McLeod P, Coffey S, Sneddon K, Williams M, Kerr A, Pemberton J. Clinically Acquired High Sensitivity Cardiac Troponin T is a Poor Predictor of Reduced Left Ventricular Ejection Fraction After ST Elevation Myocardial Infarction: A National Cohort Study-ANZACS-QI 65. Heart Lung Circ. 2022;31:1513-1523. doi: 10.1016/j.hlc.2022.07.014.36041986
]Open DOISearch in Google Scholar
[
41. Brzezinski RY, Melloul A, Berliner S, et al. Early Detection of Inflammation-Prone STEMI Patients Using the CRP Troponin Test (CTT). J Clin Med. 2022;11:2453. doi: 10.3390/jcm11092453.910504435566579
]Open DOISearch in Google Scholar
[
42. Kaura A, Hartley A, Panoulas V, et al. Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study. PLoS Med. 2022;19:e1003911. doi: 10.1371/journal.pmed.1003911.886328235192610
]Open DOISearch in Google Scholar
[
43. Mustafic S, Ibralic AM, Loncar D. Association of Inflammatory and Hemostatic Parameters With Values of High Sensitive Troponin in Patients With Acute Coronary Syndrome. Med Arch. 2022;76:84-89. doi: 10.5455/medarh.2022.76.84-89.923346335774044
]Open DOISearch in Google Scholar
[
44. Tsai MK, Lai CH, Hung CL, Wu KY. Troponin I Cutoff for Non-ST-Segment Elevation Myocardial Infarction in Sepsis. Mediators Inflamm. 2022;2022:5331474. doi: 10.1155/2022/5331474.916882435677736
]Open DOISearch in Google Scholar
[
45. Gallacher PJ, Miller-Hodges E, Shah ASV, et al. High-sensitivity cardiac troponin and the diagnosis of myocardial infarction in patients with kidney impairment. Kidney Int. 2022;102:149-159. doi: 10.1016/j.kint.2022.02.019.35271932
]Open DOISearch in Google Scholar
[
46. Wan Nur Aimi WMZ, Noorazliyana S, Tuan Salwani TI, Adlin Zafrulan Z, Najib Majdi Y, Noor Azlin Azraini CS. Elevation of Highly Sensitive Cardiac Troponin T Among End-Stage Renal Disease Patients Without Acute Coronary Syndrome. Malays J Med Sci. 2021;28:64-71. doi: 10.21315/mjms2021.28.5.6.879397335115888
]Open DOISearch in Google Scholar
[
47. Ajie OI, Azinge EC, Bello BT, Oshodi TA, Soriyan OO, Udenze IC. Clinical Significance of Elevated Levels of Cardiac Troponin T in Patients with Chronic Kidney Disease at Lagos University Teaching Hospital, Lagos. West Afr J Med. 2022;39:3-10.10.55891/wajm.v39i1.85
]Search in Google Scholar
[
48. Vitolo M, Malavasi VL, Proietti M, et al. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry. Eur J Intern Med. 2022;99:45-56. doi: 10.1016/j.ejim.2022.01.025.35177307
]Open DOISearch in Google Scholar
[
49. Koechlin L, Boeddinghaus J, Nestelberger T, et al. Lower diagnostic accuracy of hs-cTnI in patients with prior coronary artery bypass grafting. Int J Cardiol. 2022;354:1-6. doi: 10.1016/j.ijcard.2022.02.025.35189168
]Open DOISearch in Google Scholar
[
50. Ticinesi A, Nouvenne A, Cerundolo N, et al. Accounting for frailty and multimorbidity when interpreting high-sensitivity troponin I tests in oldest old. J Am Geriatr Soc. 2022;70:549-559. doi: 10.1111/jgs.17566.929912034792185
]Open DOISearch in Google Scholar
[
51. Khetpal V, Berkowitz J, Vijayakumar S, et al. Long-term Cardiovascular Manifestations and Complications of COVID-19: Spectrum and Approach to Diagnosis and Management. R I Med J (2013). 2022;105:16-22.
]Search in Google Scholar
[
52. Iorio A, Lombardi CM, Specchia C, et al. Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study). Am J Cardiol. 2022;167:125-132. doi: 10.1016/j.amjcard.2021.11.054.876795335063263
]Open DOISearch in Google Scholar
[
53. Skoda R, Juhász V, Dohy Z, et al. The effect of COVID-19 pandemic on myocardial infarction care and on its prognosis – Experience at a high volume Hungarian cardiovascular center. Physiol Int. 2022;109:419-426. doi: 10.1556/2060.2022.00083.36223273
]Open DOISearch in Google Scholar
[
54. Roos A, Edgren G, Holzmann MJ. Temporal Changes of Stable High-Sensitivity Cardiac Troponin T Levels and Prognosis. J Am Heart Assoc. 2022;11:e025082. doi: 10.1161/JAHA.121.025082.923869835621209
]Open DOISearch in Google Scholar
[
55. Biener M, Giannitsis E, Hogrefe K, et al. Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study. Clin Res Cardiol. 2022;111:333-342. doi: 10.1007/s00392-021-01952-6.887312834694435
]Open DOISearch in Google Scholar
[
56. Chapman AR, Lee KK, McAllister DA, et al. Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome. JAMA. 2017;318:1913-1924. doi: 10.1001/jama.2017.17488. Erratum in: JAMA. 2018;319:1168. Soerensen NA [corrected to Sorensen NA].571029329127948
]Open DOISearch in Google Scholar
[
57. Horiuchi Y, Wettersten N, Patel MP, et al. Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndrome. Coron Artery Dis. 2022;33:376-384. doi: 10.1097/MCA.0000000000001135.35880560
]Open DOISearch in Google Scholar
[
58. Hartikainen TS, Goßling A, Sörensen NA, et al. Prognostic Implications of a Second Peak of High-Sensitivity Troponin T After Myocardial Infarction. Front Cardiovasc Med. 2022;8:780198. doi: 10.3389/fcvm.2021.780198.884176735174220
]Open DOISearch in Google Scholar
[
59. Rubini Gimenez M, Twerenbold R, Jaeger C, et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med. 2015;128:861-870.e4. doi: 10.1016/j.amjmed.2015.01.046.25840034
]Open DOISearch in Google Scholar
[
60. Twerenbold R, Costabel JP, Nestelberger T, et al. Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction. J Am Coll Cardiol. 2019;74:483-494. doi: 10.1016/j.jacc.2019.05.046.31345421
]Open DOISearch in Google Scholar
[
61. Nomura O, Hashiba K, Kikuchi M, et al. Performance of the 0-Hour/1-Hour Algorithm for Diagnosing Myocardial Infarction in Patients With Chest Pain in the Emergency Department – A Systematic Review and Meta-Analysis. Circ Rep. 2022;4:241-247. doi: 10.1253/circrep.CR-22-0001.916851135774074
]Open DOISearch in Google Scholar
[
62. Khan A, Saleem MS, Willner KD, et al. Association of Chest Pain Protocol-Discordant Discharge With Outcomes Among Emergency Department Patients With Modest Elevations of High-Sensitivity Troponin. JAMA Netw Open. 2022;5:e2226809. doi: 10.1001/jamanetworkopen.2022.26809.937974435969395
]Open DOISearch in Google Scholar
[
63. van den Berg P, Collinson P, Morris N, Body R. Diagnostic accuracy of a high-sensitivity troponin I assay and external validation of 0/3 h rule out strategies. Eur Heart J Acute Cardiovasc Care. 2022;11:127-136. doi: 10.1093/ehjacc/zuab102.35136994
]Open DOISearch in Google Scholar
[
64. Breuckmann F, Settelmeier S, Rassaf T, et al. Survey of clinical practice pattern in Germany’s certified chest pain units: Adherence to the European Society of Cardiology guidelines on non-ST-segment elevation acute coronary syndrome. Herz. 2022;47:543-552. doi: 10.1007/s00059-021-05079-2.857764534755215
]Open DOISearch in Google Scholar
[
65. Hariri E, Kassas I, Hammoud MA, et al. Same day discharge following non-elective PCI for non-ST elevation acute coronary syndromes. Am Heart J. 2022;246:125-135. doi: 10.1016/j.ahj.2021.12.015.34998967
]Open DOISearch in Google Scholar
[
66. Clerico A, Zaninotto M, Aimo A, et al. Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy. Clin Chem Lab Med. 2021;60:169-182. doi: 10.1515/cclm-2021-1085.34927403
]Open DOISearch in Google Scholar
[
67. Sandeman D, Syed MBJ, Kimenai DM, et al. Implementation of an early rule-out pathway for myocardial infarction using a high-sensitivity cardiac troponin T assay. Open Heart. 2021;8:e001769. doi: 10.1136/openhrt-2021-001769.862741234824100
]Open DOISearch in Google Scholar
[
68. Tjora HL, Steiro OT, Langørgen J, et al. Diagnostic Performance of Novel Troponin Algorithms for the Rule-Out of Non-ST-Elevation Acute Coronary Syndrome. Clin Chem. 2022;68:291-302. doi: 10.1093/clinchem/hvab225.34897415
]Open DOISearch in Google Scholar
[
69. Chuang MA, Gnanamanickam ES, Karnon J, et al. Cost effectiveness of a 1-hour high-sensitivity troponin-T protocol: An analysis of the RAPID-TnT trial. Int J Cardiol Heart Vasc. 2021;38:100933. doi: 10.1016/j.ijcha.2021.100933.872842735024428
]Open DOISearch in Google Scholar
[
70. Suh EH, Tichter AM, Ranard LS, et al. Impact of a rapid high-sensitivity troponin pathway on patient flow in an urban emergency department. J Am Coll Emerg Physicians Open. 2022;3:e12739. doi: 10.1002/emp2.12739.907123735571147
]Open DOISearch in Google Scholar
[
71. Couch LS, Sinha A, Navin R, et al. Rapid risk stratification of acute coronary syndrome: adoption of an adapted European Society of Cardiology 0/1-hour troponin algorithm in a real-world setting. Eur Heart J Open. 2022;2:oeac048. doi: 10.1093/ehjopen/oeac048.940425436032815
]Open DOISearch in Google Scholar
[
72. Bozdereli Berikol G, Aydın H, Doğan H. Early discharging patients with chest pain using EDACS-ADP and COMPASS-MI risk predictors. Heart Vessels. 2022;37:1316-1325. doi: 10.1007/s00380-022-02036-9.885010235133498
]Open DOISearch in Google Scholar
[
73. Gohbara M, Iwahashi N, Okada K, et al. A Simple Risk Score to Differentiate Between Coronary Artery Obstruction and Coronary Artery Spasm of Patients With Acute Coronary Syndrome Without Persistent ST-Segment Elevation. Circ J. 2022;86:1509-1518. doi: 10.1253/circj.CJ-22-0096.35599005
]Open DOISearch in Google Scholar
[
74. Antwi-Amoabeng D, Roongsritong C, Taha M, et al. SVEAT score outperforms HEART score in patients admitted to a chest pain observation unit. World J Cardiol. 2022;14:454-461. doi: 10.4330/wjc.v14.i8.454.945325736160811
]Open DOISearch in Google Scholar
[
75. Dupuy AM, Pasquier G, Thiebaut L, Roubille F, Sebbane M, Cristol JP. Additive value of bioclinical risk scores to high sensitivity troponins-only strategy in acute coronary syndrome. Clin Chim Acta. 2021;523:273-284. doi: 10.1016/j.cca.2021.10.008.34648808
]Open DOISearch in Google Scholar
[
76. Matuskowitz AJ, Hall JP, Gregoski MJ, Saef SH. Clinician Perception of Risk As a Barrier to Implementation of a High-sensitivity Troponin Accelerated Diagnostic Protocol. Crit Pathw Cardiol. 2022;21:73-76. doi: 10.1097/HPC.0000000000000287.35604774
]Open DOISearch in Google Scholar
[
77. Koper LH, Frenk LDS, Meeder JG, et al. URGENT 1.5: diagnostic accuracy of the modified HEART score, with fingerstick point-of-care troponin testing, in ruling out acute coronary syndrome. Neth Heart J. 2022;30:360-369. doi: 10.1007/s12471-021-01646-8.927054634817832
]Open DOISearch in Google Scholar
[
78. Todd F, Duff J, Carlton E. Identifying low-risk chest pain in the emergency department without troponin testing: a validation study of the HE-MACS and HEAR risk scores. Emerg Med J. 2022;39:515-518. doi: 10.1136/emermed-2021-211669.34753776
]Open DOISearch in Google Scholar
[
79. Mark DG, Huang J, Ballard DW, et al. Graded Coronary Risk Stratification for Emergency Department Patients With Chest Pain: A Controlled Cohort Study. J Am Heart Assoc. 2021;10:e022539. doi: 10.1161/JAHA.121.022539.875192534743565
]Open DOISearch in Google Scholar